For the Inventor, By the Inventor

Enter assignee name

Janssen Pharmaceutica

USPTO Granted Patents = 32

Trademarks = 1

Forward Citations = 1,057

Loading Chart...

Loading Chart...

100 inventors (with patents filed for the assignee):

Michael E Rickey (6 out of 31 patents)

Jean Louis Mesens (6 out of 20 patents)

Thomas J Atkins (5 out of 11 patents)

4. Donald William Ludovici (4 out of 36 patents)

5. Jan Heeres (3 out of 124 patents)

6. R Saul Levinson (3 out of 31 patents)

7. Michael Joseph Kukla (3 out of 31 patents)

8. Loyd V Allen, Jr (3 out of 11 patents)

9. Bingnan Wang (3 out of 9 patents)

10. John Desmond Davies (3 out of 5 patents)

11. J Desmond Davies (3 out of 5 patents)

12. Dilip J Gole (3 out of 4 patents)

13. Lucien Maria Henricus Koymans (2 out of 32 patents)

14. Koen Jeanne Alfons Van Aken (2 out of 24 patents)

15. Paul Adriaan Jan Janssen (2 out of 35 patents)

32 patents: Sort by Forward Citations

1. 8765979 - Synthesis of (2S-cis)-2-(bromomethyl)-2-(4-chlorophenyl)-1,3 dioxolane-4-methanol methanesulfonate(ester) (2014-07-01),

2. 8653263 - Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators (2014-02-18),

3. 8653099 - Cold menthol receptor antagonists (2014-02-18),

4. 7652014 - Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors (2010-01-26),

5. 7638518 - Substituted pyrazole kinase inhibitors (2009-12-29),

6. 7449575 - Substituted diamino-1,3,5-triazine derivatives (2008-11-11),

7. 7276510 - HIV replication inhibitors (2007-10-02),

8. 7125878 - Substituted pyrroline kinase inhibitors (2006-10-24),

9. 7118763 - Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles (2006-10-10),

10. 7060435 - Genotyping cytochrome expression (2006-06-13),

11. 6531312 - Polynucleotide encoding hCDS1, a human cell-cycle checkpoint kinase (2003-03-11),

12. 6197779 - HIV inhibiting pyrimidine derivative (2001-03-06),

13. 6110921 - Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and (2000-08-29),

14. 5965168 - Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and (1999-10-12),

15. 5807576 - Rapidly dissolving tablet (1998-09-15),

Janssen Pharmaceutica is a leading pharmaceutical company that develops innovative solutions to improve the health and well-being of people around the world. With a focus on research and development, Janssen is committed to creating new treatments for a wide range of medical conditions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

32 Patents

#1 in NV

#10,227 in Belgium

#20,053 in the World

Janssen Pharmaceutica

Forward Citations = 1,057

100 inventors:

Michael E Rickey (6 out of 31 patents)

Jean Louis Mesens (6 out of 20 patents)

Thomas J Atkins (5 out of 11 patents)

4. Donald William Ludovici (4 out of 36 patents)

5. Jan Heeres (3 out of 124 patents)

Please report any incorrect information to support@idiyas.com

Loading…